NPPB and cancer: Indeed, circulating concentrations of cardiovascular biomarker peptides like NT-proBNP, MR-proANP, MR-proADM, CT-pro-ET-1 and hsTnT are increased in an unselected population of patients with cancer prior to induction of any cardiotoxic anticancer therapy and are strongly related to all-cause mortality[10].